Skip to main content

Nonprofit · EIN 46-0475333

INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH

Tax-exempt · W HOLLYWOOD, CA 90069

Financials

$1.1M$1.3M2023$2.1M$1.4M2024$1.6M$1.5M2025
Revenue Expenses · by fiscal year end
Financials of INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$1,611,847$1,474,134$137,713$1,999,099$3,423,529-$1,424,430
December 31, 2024990$2,137,198$1,414,569$722,629$1,494,310$3,056,453-$1,562,143
December 31, 2023990$1,146,011$1,293,096-$147,085$844,637$3,129,409-$2,284,772
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$1,175,589
Program service revenue
$69,936
Investment income
$23
Royalties
$688
Net income from fundraising events
$181,420
Other revenue
$366,299

Expenses

Grants and similar amounts paid
$0
Other salaries and wages
$338,271
Salaries, compensation and benefits (total)
$389,372
Professional fundraising fees
$0
Legal fees
$9,513
Accounting fees
$12,300
Occupancy
$184,933
Travel
$1,552
Depreciation
$16,258
Program services (functional)
$695,565
Management and general (functional)
$639,337
Fundraising (functional)
$139,232

Balance sheet and other

Total assets, start of year
$1,494,310
Total assets, end of year
$1,999,099
Total liabilities, end of year
$3,423,529
Net assets, end of year
-$1,424,430
Land, buildings and equipment
$39,496
Gross receipts
$1,611,847
Employees
4
Volunteers
5
Year formed
2002
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
JAMES R BERENSON MDPRESIDENT AN
Trustee or director, Officer
15$0
GEO HARTLEY ESQVICE PRESIDE
Trustee or director, Officer
1$0
SHAHROOZ ESHAGHIAN MDSECRETARY
Trustee or director
0.5$0
CYNDIE DUNLAPDIRECTOR
Trustee or director
1$0
ROGER FISCHERDIRECTOR
Trustee or director
0.5$0
BLAKE MORRISON PHARMDDIRECTOR
Trustee or director
0.5$0
KELLEY NICHOLSDIRECTOR
Trustee or director, Officer
1$0
MICHAEL SCHIFF ESQDIRECTOR
Trustee or director
0.5$0
LARRY STEIN ESQDIRECTOR
Trustee or director
0.5$0
MERRYL WERBERDIRECTOR
Trustee or director
1$0
JESSICA YATACOTREASURER
Trustee or director
15$0
990 for the year ended December 31, 2024: 13 people
NameTitleHours / weekCompensation
JAMES R BERENSON MDPRESIDENT AN
Trustee or director, Officer
10$0
GEO HARTLEY ESQVICE PRESIDE
Trustee or director, Officer
1.5$0
SHAHROOZ ESHAGHIAN MDSECRETARY
Trustee or director
0.75$0
CYNDIE DUNLAPDIRECTOR
Trustee or director
0.75$0
ROGER FISCHERDIRECTOR
Trustee or director
0.75$0
RICHARD GARDINER MDDIRECTOR
Trustee or director
0.75$0
RICHARD KALE ESQDIRECTOR
Trustee or director
0.75$0
BLAKE MORRISON PHARMDDIRECTOR
Trustee or director
1.5$0
KELLEY NICHOLSDIRECTOR
Trustee or director, Officer
1.5$0
MICHAEL SCHIFF ESQDIRECTOR
Trustee or director
0.75$0
LARRY STEIN ESQDIRECTOR
Trustee or director
0.75$0
MERRYL WERBERDIRECTOR
Trustee or director
0.75$0
JESSICA YATACOTREASURER
Trustee or director
1$0
990 for the year ended December 31, 2023: 13 people
NameTitleHours / weekCompensation
JAMES R BERENSON MDPRESIDENT AN
Trustee or director, Officer
10$0
GEO HARTLEY ESQVICE PRESIDE
Trustee or director, Officer
1.5$0
SHAHROOZ ESHAGHIAN MDSECRETARY
Trustee or director
0.75$0
CYNDIE DUNLAPDIRECTOR
Trustee or director
0.75$0
ROGER FISCHERDIRECTOR
Trustee or director
0.75$0
RICHARD GARDINER MDDIRECTOR
Trustee or director
0.75$0
RICHARD KALE ESQDIRECTOR
Trustee or director
0.75$0
BLAKE MORRISON PHARMDDIRECTOR
Trustee or director
1.5$0
KELLEY NICHOLSDIRECTOR
Trustee or director, Officer
1.5$0
MICHAEL SCHIFF ESQDIRECTOR
Trustee or director
0.75$0
LARRY STEIN ESQDIRECTOR
Trustee or director
0.75$0
MERRYL WERBERDIRECTOR
Trustee or director
0.75$0
JESSICA YATACOTREASURER
Trustee or director
1$0

Address and contacts

Address (IRS master file)
9201 W SUNSET BLVD STE 300, W HOLLYWOOD, CA 90069-3704
In care of
% JAMES R BERENSON MD
Principal officer (990 for 2025)
JAMES R BERENSON MD, 9201 W SUNSET BLVD SUITE 300, WEST HOLLYWOOD, CA 90069
Signed the 990
JAMES R BERENSON MD, PRESIDENT AND CMO
Phone
(310) 623-1210
Return prepared by
DOVID EINSTEIN CPA APC

California records

California keeps its own records of charities and corporations. Search them by EIN 46-0475333 or by the name INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

FORM 990 PART III LINE 1 THE INSTITUTE FOR MYELOMA AND BONE CANCER RESERACH IS ESTABLISHED FOR THE FOLLOWING PURPOSES: (I) TO PROMOTE RESEARCH IN TO THE CAUSES OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, (II)TO SUPPORT THE DEVELOPMENT OF THERAPIES DESIGNED TO TREAT AND CONTROL MYELOMA, BONE CANCER, AND RELATED DISORDERS, AND (III) TO ADVANCE EFFORTS DIRECTED AT PREVENTING THE DEVELOPMENT OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, INCLUDING THE TREATMENT OF PERSONS HAVING SUCH DISEASES. THE INSTITUTE'S TWO MAJOR ACTIVITIES WILL BE (1) RESEARCH RELATED TO THE CAUSES OF MYELOMA AND RELATED DISORDERS AND (2) DEVELOPMENT OF THERAPIES TO PREVENT AND TREAT MYELOMA AND RELATED DISORDERS.

990 for the year ended December 31, 2025

Program accomplishments

  • ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS.
    Expenses $676,563
  • ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS.
    Expenses $19,002

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
46-0475333
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2002
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$1,999,099
Income (IRS master file)
$1,611,847

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$1,611,847$1,474,134$1,999,099XML
990December 2024$2,137,198$1,414,569$1,494,310XML
990December 2023$1,146,011$1,293,096$844,637XML
990December 2022$2,303,328$1,450,344$660,470IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 46-0475333).

Questions about INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH

What is the EIN of INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH?
The employer identification number (EIN) of INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH is 46-0475333.
Is INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2002.
Are donations to INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH?
The 990 for the year ended December 31, 2025 names JAMES R BERENSON MD.
Who are the officers and directors of INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH?
The 990 for the year ended December 31, 2025 lists 11 people; 0 received compensation from the organization.
How much revenue does INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH have?
On its 990 for the year ended December 31, 2025 it reported revenue of $1,611,847, expenses of $1,474,134 and total assets of $1,999,099 at year end.

Other nonprofits in W HOLLYWOOD

All nonprofits in W HOLLYWOOD · California · Voluntary health associations and medical disciplines